CA2002000A1 - Agglutinine extraite d'echinodermes et methode d'extraction - Google Patents

Agglutinine extraite d'echinodermes et methode d'extraction

Info

Publication number
CA2002000A1
CA2002000A1 CA 2002000 CA2002000A CA2002000A1 CA 2002000 A1 CA2002000 A1 CA 2002000A1 CA 2002000 CA2002000 CA 2002000 CA 2002000 A CA2002000 A CA 2002000A CA 2002000 A1 CA2002000 A1 CA 2002000A1
Authority
CA
Canada
Prior art keywords
echinoderm
endotoxin
sigma cat
group
phenol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2002000
Other languages
English (en)
Inventor
Max Moseley
Alastair Wardlaw
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA 2002000 priority Critical patent/CA2002000A1/fr
Priority to JP2514677A priority patent/JPH06504112A/ja
Priority to EP19900915740 priority patent/EP0498820A1/fr
Priority to PCT/CA1990/000371 priority patent/WO1991006867A1/fr
Priority to AU66137/90A priority patent/AU6613790A/en
Publication of CA2002000A1 publication Critical patent/CA2002000A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/579—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving limulus lysate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/50—Lipopolysaccharides; LPS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA 2002000 1989-11-01 1989-11-01 Agglutinine extraite d'echinodermes et methode d'extraction Abandoned CA2002000A1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CA 2002000 CA2002000A1 (fr) 1989-11-01 1989-11-01 Agglutinine extraite d'echinodermes et methode d'extraction
JP2514677A JPH06504112A (ja) 1989-11-01 1990-10-29 棘皮動物凝集素および抽出法
EP19900915740 EP0498820A1 (fr) 1989-11-01 1990-10-29 Agglutinine d'echinoderme et procede d'extraction associe
PCT/CA1990/000371 WO1991006867A1 (fr) 1989-11-01 1990-10-29 Agglutinine d'echinoderme et procede d'extraction associe
AU66137/90A AU6613790A (en) 1989-11-01 1990-10-29 Echinoderm agglutinin and method of extraction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2002000 CA2002000A1 (fr) 1989-11-01 1989-11-01 Agglutinine extraite d'echinodermes et methode d'extraction

Publications (1)

Publication Number Publication Date
CA2002000A1 true CA2002000A1 (fr) 1991-05-01

Family

ID=4143439

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2002000 Abandoned CA2002000A1 (fr) 1989-11-01 1989-11-01 Agglutinine extraite d'echinodermes et methode d'extraction

Country Status (5)

Country Link
EP (1) EP0498820A1 (fr)
JP (1) JPH06504112A (fr)
AU (1) AU6613790A (fr)
CA (1) CA2002000A1 (fr)
WO (1) WO1991006867A1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3915805A (en) * 1970-05-25 1975-10-28 Univ Johns Hopkins Quantitative detection of endotoxin in biological fluids
SE431228B (sv) * 1981-12-17 1984-01-23 Kenneth Soderhell Sett att bestemma bakteriella endotoxin medelst profenoloxidashaltigt blodkroppslysat fran kreftdjur eller insekter och reagens herfor

Also Published As

Publication number Publication date
WO1991006867A1 (fr) 1991-05-16
JPH06504112A (ja) 1994-05-12
AU6613790A (en) 1991-05-31
EP0498820A1 (fr) 1992-08-19

Similar Documents

Publication Publication Date Title
Moore et al. Particulate antigen uptake during immersion immunisation of fish: the effectiveness of prolonged exposure and the roles of skin and gill
Pauley et al. Characterization of a natural agglutinin present in the hemolymph of the California sea hare, Aplysia californica
Brown et al. Immunity to malaria: II. Serological response of monkeys sensitized by drug-suppressed infection or by dead parasitized cells in Freund's complete adjuvant
Denning et al. Candida albicans and the chemotaxis of polymorphonuclear neutrophils
Chowdhury et al. Toxin production by Vibrio mimicus strains isolated from human and environmental sources in Bangladesh
Symmers Opportunistic Infections: The Concept of ‘Opportunistic Infections’
Bonfanti et al. Clinical, cytological and molecular evidence of Mesocestoides sp. infection in a dog from Italy
Bowen et al. Vervet monkey disease: Studies on some physical and chemical properties of the causative agent
US4956278A (en) Anaplasma marginale antigen, antigen compositions, vaccine and process for the production of said antigen, antigen compositions and vaccine
CA2002000A1 (fr) Agglutinine extraite d'echinodermes et methode d'extraction
Latimer et al. Turkey heterophil chemotaxis to Pasteurella multocida (serotype 3, 4)-generated chemotactic factors
Wendel Neto Current concepts on the transmission of bacteria and parasites by blood components
Garratty et al. An Acquired B Antigen Associated with Proteus vulgaris Infection 1, 2
Trangle et al. Distribution of blood groups and secretor status in schistosomiasis
Anderson et al. Responses to in vitro and in vivo immunisations with Aeromonas salmonicida O antigen bacterins in rainbow trout (Oncorhynchus mykiss)
Brooke Amebiasis; Methods in Laboratory Diagnosis
Magath THE LABORATORY DIAGNOSIS OF AMEBIASIS: CLINICAL LECTURE AT CLEVELAND SESSION
Kliks et al. Neurologic angiostrongyliasis: parasitic eosinophilic menigoencephalitis
Bigalke Relapses and immunity in canine babesiosis
JP2884975B2 (ja) エンドトキシンの抽出方法
Chacko A study of the Treponema immobilizing antibody in syphilis
EP1029246B1 (fr) Procede et dispositif permettant d'empecher la degradation de l'immunoglobuline dans des secretions externes
Jamison Man meets microbes: an introduction to medical microbiology
Kreier A COMPARISON OF THE ANTIGENIC AND MORPHOLOGIC FEATURES OF ANAPLASMA MARGINALE WITH THOSE OF SEVERAL OTHER HEMOTROPIC PARASITES.
Al-Salehy et al. RELATIONSHIP BETWEEN FECAL CALPROTECTIN AND OTHER IMMUNOLOGICAL PARAMETERS IN DIARRHEAL CHILDREN INFECTED WITH ENTAMOEBA HISTOLYTICA AND PATHOGENIC BACTERIA IN THI-QAR PROVINCE, IRAQ

Legal Events

Date Code Title Description
FZDE Dead